Company Filing History:
1 out of 2,130 
1 out of 2 Years Active: 2011
Title: Innovations of Fabrio Prati in β-Lactamase Inhibition
Introduction
Fabrio Prati is a notable inventor based in Reggio Emilia, Italy. He has made significant contributions to the field of biochemistry, particularly in the development of inhibitors for β-lactamase enzymes. His work focuses on creating compounds that enhance the effectiveness of antibiotic treatments.
Latest Patents
Fabrio Prati holds a patent for "Nanomolar β-lactamase inhibitors - New carboxyphenyl-glycylboronic acid transition-state analog inhibitors." This innovative class of compounds is effective against class C β-lactamase AmpC. The new compounds improve inhibition by over two orders of magnitude compared to analogous glycylboronic acids, with Ki values as low as 1 nM. This advancement represents a significant leap in the fight against antibiotic resistance.
Career Highlights
Throughout his career, Fabrio Prati has worked with prestigious institutions, including Northwestern University and the University of Modena. His research has focused on the development of novel compounds that can effectively combat bacterial resistance to antibiotics.
Collaborations
Fabrio Prati has collaborated with Brian K Shoichet, a prominent figure in the field of medicinal chemistry. Their joint efforts have contributed to the advancement of research in β-lactamase inhibitors.
Conclusion
Fabrio Prati's innovative work in the development of β-lactamase inhibitors showcases his commitment to addressing critical challenges in antibiotic resistance. His contributions are vital for the future of effective antibiotic therapies.